Browsing: Wellness Tips

Setmelanotide, a melanocortin-4 receptor agonist, significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The New England Journal of Medicine. Although focused primarily on patients with craniopharyngioma, this study addresses a clinically important survivorship issue: the management of…

Many of us underestimate the power of a good night’s sleep, often sacrificing those precious hours for work, entertainment, or other commitments. However, recent research from Columbia University suggests that even a modest reduction in sleep can have significant implications for our health, particularly in terms of weight gain

Children and adults living with a rare condition that causes rapid, uncontrollable weight gain now have a new treatment option following the U.S. Food and Drug Administration’s approval of setmelanotide, based on results from the phase 3 TRANSCEND clinical trial, published in The New England Journal of Medicine